Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

9.57

-0.13 (-1.34%)

At close: Jan 30, 2025, 4:00 PM

9.51

-0.06 (-0.63%)

After-hours: Jan 30, 2025, 4:10 PM EST

Anavex Life Sciences Market Cap

Anavex Life Sciences has a market cap or net worth of $811.68 million as of January 30, 2025. Its market cap has increased by 65.08% in one year.

Market Cap

811.68M

Enterprise Value

654.90M

1-Year Change

65.08%

Ranking

#2634

Market Cap Chart

Since January 25, 2007, Anavex Life Sciences's market cap has increased from $59.50M to $811.68M, an increase of 1,264.18%. That is a compound annual growth rate of 15.60%.

Market Cap History

Date	Market Cap	% Change
Jan 29, 2025	822.70M	-9.68%
Dec 31, 2024	910.90M	19.20%
Dec 29, 2023	764.20M	5.86%
Dec 30, 2022	721.90M	-45.24%
Dec 31, 2021	1.32B	264.55%
Dec 31, 2020	361.60M	148.69%
Dec 31, 2019	145.40M	100.00%
Dec 31, 2018	72.70M	-48.95%
Dec 29, 2017	142.40M	-9.24%
Dec 30, 2016	156.90M	-18.58%
Dec 31, 2015	192.70M	1,752.88%
Dec 31, 2014	10.40M	11.83%
Dec 31, 2013	9.30M	-61.09%
Dec 31, 2012	23.90M	-28.01%
Dec 30, 2011	33.20M	-63.79%
Dec 31, 2010	91.70M	102.88%
Dec 31, 2009	45.20M	-12.23%
Dec 31, 2008	51.50M	-48.91%
Dec 31, 2007	100.80M	69.41%

View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	728.17B
UnitedHealth Group	497.53B
Novo Nordisk	389.08B
Johnson & Johnson	363.86B
AbbVie	310.63B
Merck & Co.	245.83B
Thermo Fisher Scientific	222.03B
Abbott Laboratories	221.96B

Market Cap Rankings